A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration -U.S. President Joe Biden's administration is expected to announce this week the purchase of 10 million courses of Pfizer Inc's experimental COVID-19 pill, the Washington Post reported on Tuesday https://www.washingtonpost.com/health/2021/11/16/administration-purchases-pfizer-anti-covid-pill, citing people familiar with the matter.
Earlier this month, Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, said the pill https://reut.rs/3oxaxnz cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial. Pfizer expects to submit interim trial results for the pill, branded Paxlovid, to the Food and Drug Administration before the Nov. 25 U.S. Thanksgiving holiday.
The pill will compete with Merck & Co Inc's similar oral drug, molnupiravir, which was shown to halve the chances of dying or hospitalization for COVID-19 patients at high risk of serious illness. Merck applied for U.S. emergency use authorization for its drug in October and has already received regulatory clearance in Britain.
The price struck between the administration and Pfizer for its drug is less than that for the Merck pill, closer to $500 per treatment, the report said, adding that the final details have not been chalked out.Our goal is to create a safe and engaging place for users to connect over interests and passions.
Tax dollars just bought 10M doses of experimental drugs. When did we become an investment partner in Pfizer-Mectin?
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 live updates: 21 states see at least 10% jump in daily casesNEW: Pfizer has asked the FDA to authorize its COVID-19 pill, the company has announced in a press release. Both Merck and Pfizer are working on pills that appear very effective at keeping patients out of the hospital, according to the companies.
Source: ABC - 🏆 471. / 51 Read more »
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Source: bbchealth - 🏆 143. / 63 Read more »
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. mikewsyx6 I ran across a documentary called 'Covid-19, Race for the Vaccine' about Pfizer's efforts to get the vaccine out. It's well worth watching. Glad they're willing to share this new pill to help people, not their bottom line. kxly4news This is all turning out to be very lucrative for pfizer. Good thing they got all that money and support from Operation Warp Speed huh? Thank you pfizer
Source: AP - 🏆 728. / 51 Read more »
Pfizer Licenses Promising Covid-19 Pill to U.N.-Backed NonprofitPfizer is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. Because Ivermectine was too cheap and already proven to be effective...
Source: WSJ - 🏆 98. / 63 Read more »
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. Gosh they are making so much money.... That's the general idea isn't it? You can keep your nauseating pill Wish those on here having a go would actually read it first rather than making themselves look daft Test on the poor ...hah
Source: CNN - 🏆 4. / 95 Read more »
Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Source: YahooNews - 🏆 380. / 59 Read more »